Cost-effectiveness of HCV screening: a systematic review of the literature from 2007 to 2012

Autor: Alessandro Camera, Stefania Boccia, Carolina Ianuale

Publikováno v: Epidemiology, Biostatistics, and Public Health; V. 10 N. 3 (2013): Observing Real World Clinical Practice
Epidemiology, Biostatistics, and Public Health; Vol. 10 No. 3 (2013): Observing Real World Clinical Practice
Epidemiology Biostatistics and Public Health, Vol 10, Iss 3 (2013)
Epidemiology, Biostatistics and Public Health; Vol 10, No 3 (2013): Observing Real World Clinical Practice

Background: currently, 123-170 million people in the world are infected with Hepatitis C Virus (HCV) and 75% of them remain undiagnosed. HCV-positive individuals will develop Chronic Hepatitis C (CHC) or hepatocellular carcinoma (HCC) within 25 years

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0196b00dc7cfa6df31b3a23815c07fc9
https://doi.org/10.2427/8767